Peaceful protest as a means for overcoming discrimination
Pradnya Palande's passion for improving human health through scientific research began during her graduate studies, and has continued to the present day through her work with Reliance Life Sciences (RLS) of India. Palande, a 2010-2011 Corporate Affiliates Fellow, holds a master's degree in zoology, with a specialization in animal physiology and a minor in biotechnology. "I used to dream of getting a job in the biotechnology industry," she says. Within just a few short months of graduating, Palande began working for RLS, and she has enjoyed serving the company for the past nine years.
RLS belongs to the Reliance Group, one of India's
largest corporate entities. It conducts research in a wide variety of areas,
such as stem cell therapy, molecular medicine, and industrial biotechnology,
and it offers products ranging from therapeutic proteins to tissue-cultured plants.
"RLS is a life sciences company in the truest sense," Palande states. In her
role as a team leader for the company's biopharmaceuticals division, which is
headed by Dr. Venkata Ramana, she conducts literature searches and strategic
planning for new research projects, and also supports regulatory audits. In
addition to her primary duties, Palande is dedicated to her role as secretary
of the safety observation committee. "RLS believes in safety and a safe working
culture," Palande emphasizes. "It is a perfect place for me to work."
During her year at the Walter H. Shorenstein Asia-Pacific Research Center
(Shorenstein APARC), Palande is conducting cancer-related research in a
laboratory under the direction of Cliff L. Wang of the Department of Chemical
Engineering. Her Shorenstein APARC advisors are Rafiq Dossani, a senior
research scholar, and Karen Eggleston, the director of the Asia Health Policy
Program. Palande and her fellow researchers in Wang's lab are studying the population
dynamics of cancer cells. In the process of cancer development, Palande
explains, it is thought that cells often develop high mutational activity
before accumulating mutations that lead to cancer. Mutations—changes in the
genome sequence—can be advantageous, benign, or harmful to cells. Palande is examining
whether a high mutation rate provides a survival advantage to cancer cells. For
this, she is studying the activation-induced cytidine deaminase (AID) enzyme,
which plays a key role in the development of immune response in the human body.
The goal of the project is to provide insight into the nature of cancer
development, and also to give direction for the prevention of chemotherapy
resistance due to AID activity.
"Before I leave for India, I would like to complete my project successfully in
a way that will instigate future research in cancer biology," Palande says.
Upon returning to RLS, she intends to apply some of the concepts that she has
gained while conducting research at Stanford. She also hopes to build upon the
Stanford management classes that she has been auditing, studying the subject in
more detail with the intention of utilizing it in her work at RLS.
"It has been a great privilege for me to work at Stanford, and it has been an
amazing experience," she states. "Interacting with people from various
backgrounds has been enlightening. Also, I am quite impressed by the
professionalism of people [in the United States], their helping nature, and
their free way of life. I love it." She adds that through her Stanford research
and classes, her horizons have been broadened.
As passionate about the natural world as she is about scientific research,
Palande looks forward to traveling more before returning to India. "I love
traveling to be close to nature," she says. Also something of an adventurer,
she has taken a rock-climbing course and has tried skydiving. Inspired by the
range of activities in the United States, she plans to take an activity class,
such as dance, after returning to India. "I want to keep myself as active and
healthy as possible," she says with a smile.
As the United States struggles to emerge from recession, India and China's continued robust growth is the subject of much interest and concern. Council on Foreign Relations (CFR) Senior Fellow Adam Segal will talk about his new book Advantage: How American Innovation Can Overcome the Asian Challenge, analyzing Asia's technological rise, questioning assumptions about the United States inevitable decline, and explaining how America can preserve and improve its position in the global economy by optimizing its strength of moving ideas from the lab to the marketplace.
In his book, Segal argues that the emergence of India and China does not mean the end of American economic and technological power. Instead, the United States should now leverage its many advantages.
Through his research, Segal concludes the United States has an advantage over Asia in the realm of the software of innovation. “In America, your ideas can make you rich. Intellectual property is protected, and individual scientists are able to exploit their breakthroughs for commercial gains,” he writes. “It is time to realize that software in its most expansive sense offers the most opportunities for the United States to ensure its competitive place in the world.” The challenge is “to recover a culture of innovation that was driven underground, overshadowed by sexy credit default swaps and easy spending.”
Speaker
Adam Segal is the Ira A. Lipman senior fellow for counterterrorism and national security studies at the Council on Foreign Relations (CFR). An expert on security issues, technology development, and Chinese domestic and foreign policy, Dr. Segal currently leads study groups on cybersecurity and cyber conflict as well as Asian innovation and technological entrepreneurship. His new book Advantage: How American Innovation Can Overcome the Asian Challenge (W.W. Norton, 2011) looks at the technological rise of Asia. Dr. Segal is a research associate of the National Asia Research Program and was the project director for a CFR-sponsored independent task force on Chinese military modernization.
Before coming to CFR, Dr. Segal was an arms control analyst for the China Project at the Union of Concerned Scientists. There, he wrote about missile defense, nuclear weapons, and Asian security issues. Dr. Segal has been a visiting scholar at the Massachusetts Institute of Technology’s Center for International Studies, Shanghai Academy of Social Sciences, and Tsinghua University in Beijing. He has taught at Vassar College and Columbia University. Dr. Segal is the author of Digital Dragon: High-Technology Enterprises in China (Cornell University Press, 2003), as well as several articles and book chapters on Chinese technology policy. His work has recently appeared in the International Herald Tribune, Financial Times, Washington Quarterly, Los Angeles Times, and Foreign Affairs. Dr. Segal currently writes for the CFR blog, “Asia Unbound".
Dr. Segal has a BA and PhD in government from Cornell University, and an MA in international relations from the Fletcher School of Law and Diplomacy, Tufts University. He reads and speaks Chinese.
Philippines Conference Room
Paul Wise is a clinical professor of pediatrics and a CHP/PCOR core faculty member. His work focuses on children's health policy; health disparities by race, ethnicity and socioeconomic status; and the interaction of genetics and the environment as these factors influence child and maternal health.
Before coming to Stanford in July 2004, he was a professor of pediatrics at Boston University and vice-chief of Social Medicine and Health Inequalities at Brigham and Women's Hospital. He previously served as director of emergency and primary care services at the Children's Hospital of Boston, and as director of the Harvard Institute for Reproductive and Child Health at Harvard Medical School. He has also served as a special expert at the National Institutes of Health and as special assistant to the U.S. Surgeon General.
Wise has worked to improve healthcare practices and policies in developing countries. He is involved in child health projects in India, South Africa and Latin America, targeting diseases such as tuberculosis and AIDS. He currently chairs the steering committee of the NIH's Global Network for Maternal and Child Health Research, and he has served on many other boards and committees including the Physicians' Task Force on Hunger and the American Academy of Pediatrics' Consortium on Health Disparities. He has received honors from organizations including the American Public Health Association, the March of Dimes, and the New York Academy of Medicine.
He received a BA in Latin American studies from Cornell University, an MD from Cornell University and an MPH from the Harvard School of Public Health. He completed a residency in pediatrics at Children's Hospital Medical Center in Boston.
CISAC Conference Room
Dr. Paul Wise is dedicated to bridging the fields of child health equity, public policy, and international security studies. He is the Richard E. Behrman Professor of Child Health and Society and Professor of Pediatrics, Division of Neonatology and Developmental Medicine, and Health Policy at Stanford University. He is also co-Director, Stanford Center for Prematurity Research and a Senior Fellow in the Center on Democracy, Development, and the Rule of Law, and the Center for International Security and Cooperation, Freeman Spogli Institute for International Studies, Stanford University. Wise is a fellow of the American Academy of Arts and Sciences and has been working as the Juvenile Care Monitor for the U.S. Federal Court overseeing the treatment of migrant children in U.S. border detention facilities.
Wise received his A.B. degree summa cum laude in Latin American Studies and his M.D. degree from Cornell University, a Master of Public Health degree from the Harvard School of Public Health and did his pediatric training at the Children’s Hospital in Boston. His former positions include Director of Emergency and Primary Care Services at Boston Children’s Hospital, Director of the Harvard Institute for Reproductive and Child Health, Vice-Chief of the Division of Social Medicine and Health Inequalities at the Brigham and Women’s Hospital and Harvard Medical School and was the founding Director or the Center for Policy, Outcomes and Prevention, Stanford University School of Medicine. He has served in a variety of professional and consultative roles, including Special Assistant to the U.S. Surgeon General, Chair of the Steering Committee of the NIH Global Network for Women’s and Children’s Health Research, Chair of the Strategic Planning Task Force of the Secretary’s Committee on Genetics, Health and Society, a member of the Advisory Council of the National Institute of Child Health and Human Development, NIH, and the Health and Human Secretary’s Advisory Committee on Infant and Maternal Mortality.
Wise’s most recent U.S.-focused work has addressed disparities in birth outcomes, regionalized specialty care for children, and Medicaid. His international work has focused on women’s and child health in violent and politically complex environments, including Ukraine, Gaza, Central America, Venezuela, and children in detention on the U.S.-Mexico border.
By deemphasizing the role of nuclear weapons in US security policy, the 2010 Nuclear Posture Review (NPR) could lead India to slow or halt the growth of its nuclear weapons capabilities and to adopt a less assertive nuclear doctrine; however, the NPR is unlikely to have this effect on India's nuclear program. This is the case for two reasons. First, Indian leaders do not seek to emulate US nuclear behavior; they formulate policy based primarily on their assessment of the security threats facing India. Second, Indians do not think that the NPR augurs major changes in US nuclear policy. Thus, it will not alter the international strategic environment sufficiently to enable India to relax its nuclear posture. In fact, Indian strategists believe that the new US policy fails even to match India's current degree of nuclear restraint. Therefore, according to Indian experts, the NPR will have little impact on India.